Next 10 |
2024-05-18 11:58:26 ET More on Boston Scientific Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript Boston Scientific Corporation 2024 Q1 - Results - Earnings Call Presentation Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash ...
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker ...
2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors PR Newswire MARLBOROUGH, Mass. , May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immedi...
2024-05-07 16:35:22 ET Billionaire hedge fund manager Steve Cohen, who is the founder of Point72 Asset Management, has let go of at least seven long-short equity portfolio managers, according to a report by Business Insider.... Read the full article on Seeking Alpha For further ...
2024-05-07 09:01:37 ET Apple ( NASDAQ: AAPL ) recently updated its capital return plan by adding a $110B to its buyback program. According to data highlighted by Mizuho, this massive buyback program is larger than 84% of the stocks that sit inside the S&P 500.... Read ...
2024-05-04 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many Wall Street investors keep a close eye on the opinions of major brokerages, such as Citigroup (NYSE: C ). Therefore, today we’ll explore three promising growth...
2024-04-26 07:15:03 ET Barclays analyst issues OVERWEIGHT recommendation for BSX on April 26, 2024 05:04AM ET. The previous analyst recommendation was Overweight. BSX was trading at $73.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-04-25 08:15:07 ET Citigroup analyst issues BUY recommendation for BSX on April 25, 2024 06:47AM ET. The previous analyst recommendation was Buy. BSX was trading at $72.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-04-25 07:00:07 ET Lawrence Biegelsen from Wells Fargo issued a price target of $82.00 for BSX on 2024-04-25 05:23:00. The adjusted price target was set to $82.00. At the time of the announcement, BSX was trading at $72.91. The overall price target consensus is at $6...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker ...
HealthEquity (NASDAQ: HQY) recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. I...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommends buying sports betting company DraftKings Inc. (NASDAQ:DKNG), proclaim...